VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Stayble Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

The STA363 treatment is a world unique, patented innovation capable of alleviating the pain of patient’s suffering from herniated discs (LDH).

  • Biotech & therapeutics
Customers
patients suffering from leg pain thought to be caused by disc herniation
Legal name
Stayble Therapeutics AB
Claim, correct or request removal

Record updated 28 September 2026

About

Stayble´s treatment is intended for patients suffering from leg pain thought to be caused by disc herniation. Our main aim is to help people who do not respond adequately to conservative treatment.

Products

Web
STA363
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy